European Pharmaceutical Review
JULY 4, 2023
As drug development professionals know, global health crises like the COVID-19 pandemic provide the public with valuable insights into how clinical research and regulatory processes work. What are the main challenges quality assurance and compliance professionals face during the drug development and review process?
Pharmaceutical Technology
JUNE 15, 2023
Drug development is already a difficult endeavor, with the vast majority of R&D efforts failing to produce a market-worthy product. Even reaching the clinical trial phase offers no guarantees, as only 12% of such drugs receive U.S. While this process is essential, it’s also slow, expensive and unpredictable.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Is Right For Me
APRIL 4, 2023
There are so many different types of careers within the field of pharmacy—from research and drug development to pharmacy informatics! It also improves care coordination and eliminates communication gaps. It involves the training of community paramedics in performing some aspects of medication reconciliation.
ID Stewardship
JUNE 6, 2023
Patient Education and Adherence : AI chatbots or virtual assistants can be developed to provide patients with on-demand information about their medications, dosages, potential side effects, and adherence strategies. AI can assist in language translation, improving communication with non-native speakers.
European Pharmaceutical Review
JUNE 24, 2022
But what are the key potential changes and how could they impact drug developers and manufacturers? He noted that within the proposals, there is likely to be a differentiation in incentives for drug development in the orphan and unmet medical need areas. Key areas of potential legislative change. Future outlook.
Pharmaceutical Technology
JULY 18, 2022
Raw ingredients themselves may also behave differently at this stage, says Ingrid Coyle, MEDELPHARM’s director corporate business development and communication. Compaction simulation is arguably the most important when dealing with oral solid dosage forms. There is a risk for variation between batches.”.
Pharmaceutical Technology
DECEMBER 6, 2022
HPAPIs may now represent more than 30% of the drug development pipeline. Within that figure, GlobalData estimates that around 60% of pipeline HPAPIs are developed to target oncology. Nowadays, you have drugs against cancer which have a very high impact even at a very low dosage.”.
Expert insights. Personalized for you.
80 
Let's personalize your content